Elon Musk’s Neuralink has raised $600 million in new funding, boosting its valuation from $3.5 billion to $9 billion, according to Semafor. The announcement follows successful chip implantations in three patients, including a non-verbal man with ALS who demonstrated communication abilities via the device. The funding boost supports Neuralink’s ongoing progress in developing brain-computer interfaces, including recent chip implants in patients with severe communication impairments. The latest funding round strengthens its finances and reflects growing investor confidence in its potential to transform healthcare and communication. Musk announced at the Qatar Economic Forum that Neuralink plans to begin clinical trials by 2026 for its Blindsight implant, which aims to restore vision in completely blind individuals.
